EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Evaluating Blood–Brain Barrier Permeability, Cytotoxicity, and Activity of Potential Acetylcholinesterase Inhibitors: In Vitro and In Silico Study

L M Maboko iD, A Theron iD, J-L Panayides, W Cordier iD, D Fisher iD, V Steenkamp iD

Pharmacology Research & Perspectives · 2024-12 · 12 (6)

DOI: 10.1002/prp2.70043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, online erschienen am 09.12.2024. Verfasst von L M Maboko und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Cholinesterase Inhibitors, Computer Simulation, Permeability. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Pretoria, Department of Science and Innovation, South Africa, Council for Scientific and Industrial Research, South Africa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acetylcholinesterase inhibitors (AChEIs) remain the first‐line treatment for Alzheimer's disease. However, these drugs are largely symptomatic and often associated with adverse effects. This study aimed to evaluate novel pharmacophores for their in vitro AChEI activity, blood–brain barrier (BBB) permeability, and cytotoxic potential, hypothesizing that a combination of AChEIs could enhance symptom management while minimizing toxicity. A library of 1453 synthetic pharmacophores was assessed using in vitro and in silico methods to determine their feasibility as an inhibitor of the AChE enzyme. An in‐house miniaturized Ellman's assay determined acellular AChEI activities, while pharmacokinetic properties were evaluated using the SwissADME web tool. The combinational effects of in silico BBB‐permeable pharmacophores and donepezil were examined using a checkerboard AChEI assay. Cytotoxicity of active compounds and their synergistic combinations was assessed in SH‐SY5Y neuroblastoma and bEnd.5 cells using the sulforhodamine B assay. Cellular AChEI activity of active in silico BBB‐permeable predicted compounds was determined using an SH‐SY5Y AChE‐based assay. An in vitro BBB model was used to assess the effect of compounds on the integrity of the bEnd.5 monolayer. Out of the screened compounds, 12 demonstrated 60% AChEI activity at 5 μM, with compound A51 showing the lowest IC 50 (0.20 μM). Five compounds were identified as BBB‐permeable, with the donepezil‐ C53 combination at ¼IC 50 exhibiting the strongest synergy (CI = 0.82). Compounds A136 and C129 , either alone or with donepezil, showed cytotoxicity. Notably, compound C53 , both alone and in combination with donepezil, demonstrated high AChEI activity and promising BBB permeability, warranting further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierCholinesterase InhibitorsComputer SimulationPermeabilityAcetylcholinesteraseHumansAnimalsDonepezilCell Line, TumorMiceCell SurvivalAlzheimer DiseaseDrug SynergismCell LineIndans

Stichwörter der Autor:innen

acetylcholinesterase inhibitionblood–brain barriercytotoxicitysynthetic compounds

Substanzen

Cholinesterase InhibitorsAcetylcholinesteraseDonepezilIndans

Autor:innen und Institutionen

  • Department of Pharmacology, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
  • Future Production: Chemicals, Council for Scientific and Industrial Research, Pretoria, South Africa.
  • Department of Medical BioSciences, Faculty of Natural Sciences, Neurobiology Research Group, University of Western Cape, Cape Town, South Africa.

ORCID-Profile: L M Maboko, A Theron, W Cordier, D Fisher, V Steenkamp

Förderung

  • University of Pretoria
  • Department of Science and Innovation, South Africa
  • Council for Scientific and Industrial Research, South Africa

Zitieren

APA

Maboko, L. M., Theron, A., Panayides, J. L., Cordier, W., Fisher, D., & Steenkamp, V. (2024). Evaluating Blood–Brain Barrier Permeability, Cytotoxicity, and Activity of Potential Acetylcholinesterase Inhibitors: In Vitro and In Silico Study. Pharmacology Research & Perspectives, 12(6). https://doi.org/10.1002/prp2.70043

Vancouver

Maboko LM, Theron A, Panayides JL, Cordier W, Fisher D, Steenkamp V. Evaluating Blood–Brain Barrier Permeability, Cytotoxicity, and Activity of Potential Acetylcholinesterase Inhibitors: In Vitro and In Silico Study. Pharmacology Research & Perspectives. 2024;12(6). doi:10.1002/prp2.70043

BibTeX
@article{Maboko2024,
  author = {Maboko, L M and Theron, A and Panayides, J-L and Cordier, W and Fisher, D and Steenkamp, V},
  title = {Evaluating Blood–Brain Barrier Permeability, Cytotoxicity, and Activity of Potential Acetylcholinesterase Inhibitors: In Vitro and In Silico Study},
  journal = {Pharmacology Research & Perspectives},
  year = {2024},
  volume = {12},
  number = {6},
  doi = {10.1002/prp2.70043}
}
Kostenlos starten →